# Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.

> **NCT06197763** · PHASE1,PHASE2 · UNKNOWN · sponsor: **St. Boniface Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Fontan Circulation

## Interventions

- **DRUG:** Colesevelam
- **OTHER:** Control Arm

## Key facts

- **NCT ID:** NCT06197763
- **Lead sponsor:** St. Boniface Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197763, "Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06197763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*